Anaphylactoid reaction after the use of sodium tetradecyl sulfate: A case report

Angiology

Volumn 58, Issue 5, 2007, Pages 644-646

  Brzoza, Zenon ^a,b   Kasperska Zajac, Alicja ^a   Rogala, Edmund ^a   Rogala, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Department of Internal Diseases Allergology and Clinical Immunology ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTAZOLINE; CILAZAPRIL; FIBRO VEIN; HYDROCORTISONE; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ANAPHYLAXIS; ARTICLE; CASE REPORT; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; RISK FACTOR; SCLEROTHERAPY; THORAX RADIOGRAPHY; VARICOSIS;

ANAPHYLAXIS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MIDDLE AGED; RISK ASSESSMENT; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM TETRADECYL SULFATE; VARICOSE VEINS;

EID: 35448979529     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706291170     Document Type: Article

References (15)

1. Zimmet SE: Sclerotherapy treatment of telangiectasis and varicose veins. Tech Vasc Interv Radiol 6: 116-120, 2003.
2. Evans Dmd, Jones DB, Cleary BK,, et al. Oesophageal varices treated by sclerotherapy: A histopathological study. Gut 23: 615-620, 1982.
3. Goldman MP: Sodium tetradecyl sulfate for sclerotherapy treatment of veins: Is compounding pharmacy solution safe? Dermatol Surg 30: 1454-1456, 2004.
4. Tretbar LL: Injection sclerotherapy for spider telangiectasias: A 20-year experience with sodium tetradecyl sulfate. J Dermatol Surg Oncol 15: 223-225, 1989.
5. Avram J.: Allergic shock after injection of sodium tetradecyl sulfate. Phlebologie 19: 171-173, 1966.
6. Rusznak C., Peebles S.: Anaphylaxis and anaphylactoid reaction: A guide to prevention, recognition, and emergent treatment. Postgrad Med 111: 101-114, 2002.
7. Johansson Sgo, O'B Hourihane J., Bousquet J.,, et al. A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force. Allergy 56: 813-824, 2001.
8. Van der Klauw MM, Wilson Jhp, Stricker BH: Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and a review of the literature. Clin Exp Allergy 26: 1355-1363, 1996.
9. Yocum MW, Khan DA: Assessment of patients who have experienced anaphylaxis: A 3-year survey. Mayo Clin Proc 69: 16-23, 1994.
10. Noppeney T., Noppeney J., Scheidt A.,, et al. Indikation und technik zur sklerotherapie bei varikose. Zentralbl Chir 126: 546-550, 2001.
11. Fronek H., Fronek A., Saltzberg G.: Allergic reactions to Sotradecol. J Dermatol Surg Oncol 15: 684, 1989.
12. Wojno TH: Sotradecol (sodium tetradecyl sulfate) injection of orbital lymphangioma. Ophthal Plast Reconstr Surg 15: 432-437, 1999.
13. Natali J., Farman T.: Implications medico-legales au cours du traitement sclerosant des varices. J Mal Vasc. 21: 227-232, 1996.
14. Shmunes E.: Allergic dermatitis to benzyl alcohol in an injectable solution. Arch Dermatol 120: 1200-1201, 1984.
15. Turvey SE, Cronin B., Arnold AD,, et al. Adverse reactions to vitamin B12 injections due to benzyl alcohol sensitivity: Successful treatment with intranasal cyanocobalamin. Allergy 59: 1023-1024, 2004.